Lamotte L C
Health Lab Sci. 1977 Jul;14(3):213-23.
The experience acquired by the Center for Diseases Control during the past 7 years in the administration of the Clinical Laboratories Improvement Act of 1967 suggests that the key indicators of reliability have been identified and that sensitive measurement of those indicators is now possible and practical. The costs of assuring high quality are inconsequential compared to the costs to the patient and taxpaying public of inaccurate test results. This objective system for evaluating clinical laboratories has been applied to licensed interstate laboratories and has been shown to be effective. This proven system has been offered to the Bureau of Health Insurance of the Social Security Administration for application to Medicare laboratories.
疾病控制中心在过去7年里实施1967年《临床实验室改进法案》所积累的经验表明，可靠性的关键指标已经确定，而且现在有可能且切实可行地对这些指标进行灵敏测量。与不准确检测结果给患者和纳税公众带来的成本相比，确保高质量的成本微不足道。这种评估临床实验室的客观系统已应用于获得许可的跨州实验室，并已证明是有效的。这个经过验证的系统已提交给社会保障管理局医疗保险局，供其应用于医疗保险实验室。
